Swallowable Weight-Loss Balloon and Semaglutide Improve Obesity-Related Sleep Apnea
The combined therapy of a swallowable weight-loss balloon and semaglutide oral formulation showed significant reductions in obstructive sleep apnea, type 2 diabetes, and hypertension in four months, according to a new study.